Trial NCT03235869

View at ClinicalTrials.gov 
Org. Study IDs: UMCC 2017.079
Secondary IDs: HUM00131550

Last trial update was posted on 2018-03-15

MeSH Interventions

Durvalumab

MeSH Conditions

Lymphoma Lymphoma, T-Cell Lymphoma, T-Cell, Cutaneous Lymphoma, T-Cell, Peripheral

Other Conditions

Cutaneous T Cell Lymphoma

Stopping Reasons

The company pulled durvalumab from heme malignancies

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID